Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study
Abstract Aberrant metabolisms have been hypothesized to precede the occurrence of hepatocellular carcinoma (HCC), therefore, we investigated biomarkers associated with subsequent HCC in peripheral bloods using metabolomic technologies. A cohort of 475 HCC-naïve liver cirrhotic patients were recruite...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/57a2d4603bc3497e936665e7b5776bd2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:57a2d4603bc3497e936665e7b5776bd2 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:57a2d4603bc3497e936665e7b5776bd22021-12-02T16:32:08ZPlasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study10.1038/s41598-020-67971-x2045-2322https://doaj.org/article/57a2d4603bc3497e936665e7b5776bd22020-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-67971-xhttps://doaj.org/toc/2045-2322Abstract Aberrant metabolisms have been hypothesized to precede the occurrence of hepatocellular carcinoma (HCC), therefore, we investigated biomarkers associated with subsequent HCC in peripheral bloods using metabolomic technologies. A cohort of 475 HCC-naïve liver cirrhotic patients were recruited and prospectively followed. A total of 39 patients developed HCC in the follow-up period. Baseline plasma metabolites were explored using untargeted nuclear magnetic resonance. Candidates were then quantified by ultra-performance liquid chromatography. A series of univairiate and multivariate analysis showed that Phenylalanine (Phe) and Glutamine (Gln) levels are associated with time to HCC, independent of viological etiologies and age. A HCC risk score R was then constructed using the polynomial combination of age, Phe and Gln in the units of micromolar (μM):$$\begin{aligned} {\text{R }} & = {\text{ Age }}* \, \left( {0.0694} \right) + {\text{ Phe }}* \, \left( {0.3399} \right) + {\text{ Phe }^{2}}* \, \left( { - 0.00188154} \right) \hfill \\ & \quad + {\text{ Gln }}* \, \left( { - 0.0133} \right) + {\text{ Gln }^{2}}* \, \left( { \, 0.00002244} \right) \hfill \\ \end{aligned}$$ R=Age∗0.0694+Phe∗0.3399+Phe2∗-0.00188154+Gln∗-0.0133+Gln2∗0.00002244 R correlates with the time to HCC significantly (Hazard ratio [HR] = 2.368, 95% confidence interval [CI] 1.760–3.187, P < 0.001). An additional cross-sectional analysis showed that Phe and Gln concentrations both correlates with HCC occurrence in the next 3 years (area under the receiver operating characteristic curve [AUC] = 0.607 and 0.629, P = 0.033 and 0.010 respectively). In conclusion, phenylalanine and glutamine concentrations in the peripheral blood correlate with subsequent HCC.Kung-Hao LiangMei-Ling ChengChi-Jen LoYang-Hsiang LinMing-Wei LaiWey-Ran LinChau-Ting YehNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-7 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Kung-Hao Liang Mei-Ling Cheng Chi-Jen Lo Yang-Hsiang Lin Ming-Wei Lai Wey-Ran Lin Chau-Ting Yeh Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| description |
Abstract Aberrant metabolisms have been hypothesized to precede the occurrence of hepatocellular carcinoma (HCC), therefore, we investigated biomarkers associated with subsequent HCC in peripheral bloods using metabolomic technologies. A cohort of 475 HCC-naïve liver cirrhotic patients were recruited and prospectively followed. A total of 39 patients developed HCC in the follow-up period. Baseline plasma metabolites were explored using untargeted nuclear magnetic resonance. Candidates were then quantified by ultra-performance liquid chromatography. A series of univairiate and multivariate analysis showed that Phenylalanine (Phe) and Glutamine (Gln) levels are associated with time to HCC, independent of viological etiologies and age. A HCC risk score R was then constructed using the polynomial combination of age, Phe and Gln in the units of micromolar (μM):$$\begin{aligned} {\text{R }} & = {\text{ Age }}* \, \left( {0.0694} \right) + {\text{ Phe }}* \, \left( {0.3399} \right) + {\text{ Phe }^{2}}* \, \left( { - 0.00188154} \right) \hfill \\ & \quad + {\text{ Gln }}* \, \left( { - 0.0133} \right) + {\text{ Gln }^{2}}* \, \left( { \, 0.00002244} \right) \hfill \\ \end{aligned}$$ R=Age∗0.0694+Phe∗0.3399+Phe2∗-0.00188154+Gln∗-0.0133+Gln2∗0.00002244 R correlates with the time to HCC significantly (Hazard ratio [HR] = 2.368, 95% confidence interval [CI] 1.760–3.187, P < 0.001). An additional cross-sectional analysis showed that Phe and Gln concentrations both correlates with HCC occurrence in the next 3 years (area under the receiver operating characteristic curve [AUC] = 0.607 and 0.629, P = 0.033 and 0.010 respectively). In conclusion, phenylalanine and glutamine concentrations in the peripheral blood correlate with subsequent HCC. |
| format |
article |
| author |
Kung-Hao Liang Mei-Ling Cheng Chi-Jen Lo Yang-Hsiang Lin Ming-Wei Lai Wey-Ran Lin Chau-Ting Yeh |
| author_facet |
Kung-Hao Liang Mei-Ling Cheng Chi-Jen Lo Yang-Hsiang Lin Ming-Wei Lai Wey-Ran Lin Chau-Ting Yeh |
| author_sort |
Kung-Hao Liang |
| title |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| title_short |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| title_full |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| title_fullStr |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| title_full_unstemmed |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| title_sort |
plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study |
| publisher |
Nature Portfolio |
| publishDate |
2020 |
| url |
https://doaj.org/article/57a2d4603bc3497e936665e7b5776bd2 |
| work_keys_str_mv |
AT kunghaoliang plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT meilingcheng plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT chijenlo plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT yanghsianglin plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT mingweilai plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT weyranlin plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy AT chautingyeh plasmaphenylalanineandglutamineconcentrationscorrelatewithsubsequenthepatocellularcarcinomaoccurrenceinlivercirrhosispatientsanexploratorystudy |
| _version_ |
1718383809662025728 |